Skip to content
PIL Logo

Cholestagel 625 mg film-coated tablets

Last Updated on eMC 13-Jun-2017 View document  | SANOFI Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13-Jun-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 3 - how to take/use

Updated on 13-May-2015 and displayed until 13-Jun-2017

Reasons for adding or updating:

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 5 - how to store
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children/adolescents

Updated on 16-Jan-2014 and displayed until 13-May-2015

Reasons for adding or updating:

  • Change to other sources of information section

Updated on 04-Sep-2012 and displayed until 16-Jan-2014

Reasons for adding or updating:

  • Change to date of revision
  • Change of contra-indications
  • Change to side-effects
  • Change to information about pregnancy or lactation

Updated on 14-Apr-2010 and displayed until 04-Sep-2012

Reasons for adding or updating:

  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use

Updated on 28-Apr-2009 and displayed until 14-Apr-2010

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 27-Apr-2009 and displayed until 28-Apr-2009

Reasons for adding or updating:

  • Improved Electronic Presentation
  • Change to date of revision

Updated on 03-Feb-2009 and displayed until 27-Apr-2009

Reasons for adding or updating:

  • Change to drug interactions

Updated on 07-Aug-2008 and displayed until 03-Feb-2009

Reasons for adding or updating:

  • Change to drug interactions

Updated on 16-Jul-2008 and displayed until 07-Aug-2008

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

SANOFI

Company image
Address

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK

Fax

+44 (0)1483 535 432

Medical Information e-mail
Telephone

+44 (0)1483 505 515

Medical Information Direct Line

+44 (0)845 372 7101

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

colesevelam hydrochloride

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue